# China NMPA Product Recall - Flexi-Slip™ Endotracheal Tube Stylet

Source: https://www.globalkeysolutions.net/records/china_product_recall/teleflex-medical/f884a4a6-c775-4a1e-b7c4-44542c4dfb8c/
Source feed: China

> China NMPA product recall for Flexi-Slip™ Endotracheal Tube Stylet by Teleflex Medical published December 22, 2011. Recall level: . The National Medical Products Administration (NMPA) announced on December 22, 2011, a voluntary reca

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Teleflex Medical is recalling its Flexi-Slip™ Endotracheal Tube Stylet cannulation guidewire.
- Company Name: Teleflex Medical
- Publication Date: 2011-12-22
- Product Name: Flexi-Slip™ Endotracheal Tube Stylet
- Recall Reason: Teleflex Medical has received complaints regarding difficulties in removing the endotracheal guidewire from the endotracheal tube and the PVC membrane covering the guidewire detaching during use. Either of these issues could lead to delays in treatment. If the PVC membrane detaches during use, it will adhere to the patient's lung tissue and must be removed via bronchoscopy.
- Discovering Company: Telif Medical Devices Trading (Shanghai) Co., Ltd.
- Manufacturing Company: Teleflex Medical
- Summary: The National Medical Products Administration (NMPA) announced on December 22, 2011, a voluntary recall by Teleflex Medical for its Flexi-Slip
Endotracheal Tube Stylet guidewire. Teleflex Medical Devices Trading (Shanghai) Co., Ltd., the responsible unit in China, initiated recall activities around December 15, 2011, following product complaints. The main issues identified were difficulty removing the guidewire from the endotracheal tube or the detachment of its PVC membrane during use. Both problems could lead to treatment delays, with a detached membrane potentially adhering to a patient's lung tissue, requiring bronchoscopy for removal.

The recall affected products sold in China (200 units), Hong Kong (180 units), and other regions including Europe, Asia Pacific, the USA, and Canada. The regulatory framework involved the NMPA requesting provincial administrations to strengthen product supervision. Required actions included immediately notifying distributors to cease shipments and isolate affected products, instructing them to notify customers to stop use and initiate returns, checking inventory, and returning products to Teleflex. The company planned to tally recallable products by December 23, 2011, arrange for customer returns, and conduct acceptance inspections for centralized processing of all recalled units.

Company: https://www.globalkeysolutions.net/companies/teleflex-medical/5312ec09-d2e9-475a-a823-43bf4934f597/